drugset / Trial / NCT01259557
Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Meditoxin® in the treatment of Essential blepharospasm.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-05
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 60 iu | Intramuscular |